HSCS - Heart Test Laboratories, Inc. Stock Price and Quote

HSCS [NASD]

Index	-	P/E	-	EPS (ttm)	-0.81	Insider Own	25.44%	Shs Outstand	8.24M	Perf Week	0.71%
Market Cap	10.07M	Forward P/E	-	EPS next Y	-1.16	Insider Trans	0.00%	Shs Float	5.90M	Perf Month	-24.66%
Income	-6.80M	PEG	-	EPS next Q	-0.14	Inst Own	0.80%	Short Float / Ratio	0.90% / 0.02	Perf Quarter	23.34%
Sales	0.01M	P/S	997.86	EPS this Y	-92.30%	Inst Trans	39.25%	Short Interest	0.05M	Perf Half Y	-17.06%
Book/sh	-0.03	P/B	-	EPS next Y	3.80%	ROA	-170.40%	Target Price	3.50	Perf Year	-
Cash/sh	0.19	P/C	5.30	EPS next 5Y	-	ROE	-	52W Range	0.71 - 6.00	Perf YTD	17.51%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-83.55%	Beta	-
Dividend %	-	Quick Ratio	1.10	Sales past 5Y	-	Gross Margin	-	52W Low	39.01%	ATR	0.15
Employees	12	Current Ratio	1.40	Sales Q/Q	-	Oper. Margin	-	RSI (14)	38.53	Volatility	8.10% 10.02%
Optionable	No	Debt/Eq	-	EPS Q/Q	52.80%	Profit Margin	-	Rel Volume	0.01	Prev Close	0.99
Shortable	Yes	LT Debt/Eq	-	Earnings	-	Payout	-	Avg Volume	2.68M	Price	0.99
Recom	2.00	SMA20	-11.33%	SMA50	-32.95%	SMA200	-37.05%	Volume	25,124	Change	0.20%

Mar-18-23 08:39AM	Heart Test Laboratories Reports Third Quarter 2023 Earnings Simply Wall St.
Mar-16-23 04:15PM	HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results GlobeNewswire -8.18%
Feb-07-23 11:04AM	HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 a.m. Pacific Time GlobeNewswire
Feb-06-23 07:30AM	HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease GlobeNewswire -17.65%
Feb-03-23 09:00AM	HeartSciences Announces Further Internationalization of its Patent Portfolio GlobeNewswire +139.44%
11:00AM	Loading…
Jan-24-23 11:00AM	Maxim Group LLC to Host the Healthcare IT Virtual Conference on Wednesday, January 25th at 8:15 A.M. ET GlobeNewswire
Jan-23-23 09:00AM	Correction: HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th GlobeNewswire
Jan-20-23 09:00AM	HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th GlobeNewswire
Jan-04-23 09:00AM	HeartSciences Appoints David R. Wells to its Board of Directors, an Experienced Capital Markets and Finance Executive GlobeNewswire
Dec-16-22 08:30AM	HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial Results GlobeNewswire
Dec-01-22 09:00AM	HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms GlobeNewswire
Nov-28-22 09:00AM	HeartSciences to Present at the 2022 RHK Disruptive Growth Conference on December 5, 2022 GlobeNewswire -5.76%
Nov-21-22 09:00AM	HeartSciences to Participate at the Benchmark Discovery One-on-One Investor Conference on December 1, 2022 GlobeNewswire
Nov-10-22 09:00AM	HeartSciences MyoVista® Technology Used to Develop AI-ECG Algorithm to Identify Patients at High-Risk of Major Adverse Cardiovascular Events GlobeNewswire
Oct-25-22 09:00AM	HeartSciences Granted European Patent for Proprietary Electrode and Cable Connections for Use with its AI-Based MyoVista® ECG GlobeNewswire +14.02%
09:00AM	Loading…
Oct-20-22 09:00AM	HeartSciences Named as a Top 10 MedTech Startup 2022 by MedTech Outlook Magazine GlobeNewswire +10.13%
Oct-19-22 09:15AM	HeartSciences Announces Major Milestone with the Issuance of CPT® Codes by the American Medical Association for ECG AI Analysis of Cardiac Dysfunction GlobeNewswire
08:45AM	EXCLUSIVE: Issuance Of New Reimbursement-Related Codes Validates Commercial Opportunity For HeartSciences' Flagship Product Benzinga
Oct-18-22 09:00AM	HeartSciences to Present at the LD Micro Main Event XV on October 26th Newsfile
Oct-06-22 09:00AM	HeartSciences to Present at MicroCap Rodeo's Windy City Roundup Conference on October 12th ACCESSWIRE
Sep-20-22 08:30AM	HeartSciences Granted U.S Patent for ECG Assessment of Heart Diastolic Function Using Artificial Intelligence GlobeNewswire
Sep-13-22 08:00AM	HeartSciences Provides Business Update and Reports First Quarter Fiscal 2023 Financial Results GlobeNewswire
Sep-12-22 08:30AM	HeartSciences to Participate and Showcase the MyoVista at the Inauguration Ceremony of the Center for Innovation at Rutgers Robert Wood Johnson University Hospital GlobeNewswire +5.00%
Sep-08-22 08:30AM	HeartSciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference GlobeNewswire
Aug-01-22 08:30AM	HeartSciences Provides Corporate Update and Reports Fiscal 2022 Financial Results GlobeNewswire +5.04%
Jul-13-22 02:03PM	HeartSciences CEO to Participate in the Benzinga All Access Event on July 15th GlobeNewswire
Jun-15-22 09:50AM	Heart Test Laboratories, Inc. Announces Pricing of $6.375 Million Initial Public Offering and Nasdaq Listing GlobeNewswire

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience